Abstract
Recent studies demonstrate that inflammatory signals regulate hematopoietic stem cells (HSCs). Granulocyte colony-stimulating factor (G-CSF) is often induced with infection and has a key role in the stress granulopoiesis response. However, its effects on HSCs are less clear. Herein, we show that treatment with G-CSF induces expansion and increased quiescence of phenotypic HSCs, but causes a marked, cell-autonomous HSC repopulating defect associated with induction of Toll-like receptor (TLR) expression and signaling. The G-CSF-mediated expansion of HSCs is reduced in mice lacking TLR2, TLR4 or the TLR signaling adaptor MyD88. Induction of HSC quiescence is abrogated in mice lacking MyD88 or in mice treated with antibiotics to suppress intestinal flora. Finally, loss of TLR4 or germ-free conditions mitigates the G-CSF-mediated HSC repopulating defect. These data suggest that low-level TLR agonist production by commensal flora contributes to the regulation of HSC function and that G-CSF negatively regulates HSCs, in part, by enhancing TLR signaling.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Accession codes
References
Baldridge MT, King KY, Goodell MA . Inflammatory signals regulate hematopoietic stem cells. Trends Immunol 2011; 32: 57–65.
King KY, Goodell MA . Inflammatory modulation of HSCs: viewing the HSC as a foundation for the immune response. Nat Rev Immunol 2011; 11: 685–692.
Boiko JR, Borghesi L . Hematopoiesis sculpted by pathogens: Toll-like receptors and inflammatory mediators directly activate stem cells. Cytokine 2012; 57: 1–8.
Sato T, Onai N, Yoshihara H, Arai F, Suda T, Ohteki T . Interferon regulatory factor-2 protects quiescent hematopoietic stem cells from type I interferon-dependent exhaustion. Nat Med 2009; 15: 696–700.
Essers MA, Offner S, Blanco-Bose WE, Waibler Z, Kalinke U, Duchosal MA et al. IFNalpha activates dormant haematopoietic stem cells in vivo. Nature 2009; 458: 904–908.
King KY, Baldridge MT, Weksberg DC, Chambers SM, Lukov GL, Wu S et al. Irgm1 protects hematopoietic stem cells by negative regulation of IFN signaling. Blood 2011; 118: 1525–1533.
Zhao X, Ren G, Liang L, Ai PZ, Zheng B, Tischfield JA et al. Brief report: interferon-gamma induces expansion of Lin(−)Sca-1(+)C-Kit(+) Cells. Stem Cells 2010; 28: 122–126.
Esplin BL, Shimazu T, Welner RS, Garrett KP, Nie L, Zhang Q et al. Chronic exposure to a TLR ligand injures hematopoietic stem cells. J Immunol 2011; 186: 5367–5375.
Gross-Weege W, Dumon K, Dahmen A, Schneider EM, Roher HD . Granulocyte colony-stimulating factor (G-CSF) serum levels in surgical intensive care patients. Infection 1997; 25: 213–216.
Panopoulos AD, Watowich SS . Granulocyte colony-stimulating factor: molecular mechanisms of action during steady state and 'emergency' hematopoiesis. Cytokine 2008; 42: 277–288.
McKinstry WJ, Li CL, Rasko JE, Nicola NA, Johnson GR, Metcalf D . Cytokine receptor expression on hematopoietic stem and progenitor cells. Blood 1997; 89: 65–71.
Richards MK, Liu F, Iwasaki H, Akashi K, Link DC . Pivotal role of granulocyte colony-stimulating factor in the development of progenitors in the common myeloid pathway. Blood 2003; 102: 3562–3568.
de Haan G, Dontje B, Engel C, Loeffler M, Nijhof W . The kinetics of murine hematopoietic stem cells in vivo in response to prolonged increased mature blood cell production induced by granulocyte colony-stimulating factor. Blood 1995; 86: 2986–2992.
Bodine DM, Seidel NE, Orlic D . Bone marrow collected 14 days after in vivo administration of granulocyte colony-stimulating factor and stem cell factor to mice has 10-fold more repopulating ability than untreated bone marrow. Blood 1996; 88: 89–97.
Winkler IG, Pettit AR, Raggatt LJ, Jacobsen RN, Forristal CE, Barbier V et al. Hematopoietic stem cell mobilizing agents G-CSF, cyclophosphamide or AMD3100 have distinct mechanisms of action on bone marrow HSC niches and bone formation. Leukemia 2012; 26: 1594–1601.
Semerad CL, Christopher MJ, Liu F, Short B, Simmons PJ, Winkler I et al. G-CSF potently inhibits osteoblast activity and CXCL12 mRNA expression in the bone marrow. Blood 2005; 106: 3020–3027.
Christopher MJ, Link DC . Granulocyte colony-stimulating factor induces osteoblast apoptosis and inhibits osteoblast differentiation. J Bone Miner Res 2008; 23: 1765–1774.
Levesque JP, Hendy J, Takamatsu Y, Simmons PJ, Bendall LJ . Disruption of the CXCR4/CXCL12 chemotactic interaction during hematopoietic stem cell mobilization induced by GCSF or cyclophosphamide. J Clin Invest 2003; 111: 187–196.
Petit I, Szyper-Kravitz M, Nagler A, Lahav M, Peled A, Habler L et al. G-CSF induces stem cell mobilization by decreasing bone marrow SDF-1 and up-regulating CXCR4. Nat Immunol 2002; 3: 687–694.
Harrison DE, Jordan CT, Zhong RK, Astle CM . Primitive hemopoietic stem cells: direct assay of most productive populations by competitive repopulation with simple binomial, correlation and covariance calculations. Exp Hematol 1993; 21: 206–219.
Fleming WH, Alpern EJ, Uchida N, Ikuta K, Spangrude GJ, Weissman IL . Functional heterogeneity is associated with the cell cycle status of murine hematopoietic stem cells. J Cell Biol 1993; 122: 897–902.
Glimm H, Oh IH, Eaves CJ . Human hematopoietic stem cells stimulated to proliferate in vitro lose engraftment potential during their S/G(2)/M transit and do not reenter G(0). Blood 2000; 96: 4185–4193.
Passegue E, Wagers AJ, Giuriato S, Anderson WC, Weissman IL . Global analysis of proliferation and cell cycle gene expression in the regulation of hematopoietic stem and progenitor cell fates. J Exp Med 2005; 202: 1599–1611.
Jorgensen HG, Copland M, Allan EK, Jiang X, Eaves A, Eaves C et al. Intermittent exposure of primitive quiescent chronic myeloid leukemia cells to granulocyte-colony stimulating factor in vitro promotes their elimination by imatinib mesylate. Clinical Cancer Res 2006; 12: 626–633.
Morrison SJ, Wright DE, Weissman IL . Cyclophosphamide/granulocyte colony-stimulating factor induces hematopoietic stem cells to proliferate prior to mobilization. Proc Natl Acad Sci USA 1997; 94: 1908–1913.
Wilson A, Laurenti E, Oser G, van der Wath RC, Blanco-Bose W, Jaworski M et al. Hematopoietic stem cells reversibly switch from dormancy to self-renewal during homeostasis and repair. Cell 2008; 135: 1118–1129.
Boyd CR, Orr SJ, Spence S, Burrows JF, Elliott J, Carroll HP et al. Siglec-E is up-regulated and phosphorylated following lipopolysaccharide stimulation in order to limit TLR-driven cytokine production. J Immunol 2009; 183: 7703–7709.
Cook DN, Wang S, Wang Y, Howles GP, Whitehead GS, Berman KG et al. Genetic regulation of endotoxin-induced airway disease. Genomics 2004; 83: 961–969.
van Zuylen WJ, Garceau V, Idris A, Schroder K, Irvine KM, Lattin JE et al. Macrophage activation and differentiation signals regulate schlafen-4 gene expression: evidence for Schlafen-4 as a modulator of myelopoiesis. PLoS One 2011; 6: e15723.
Bruckmaier RM . Gene expression of factors related to the immune reaction in response to intramammary Escherichia coli lipopolysaccharide challenge. J Dairy Res 2005; 8: 131–141.
Zheng J, Ather JL, Sonstegard TS, Kerr DE . Characterization of the infection-responsive bovine lactoferrin promoter. Gene 2005; 353: 107–117.
Fessler MB, Malcolm KC, Duncan MW, Worthen GS . A genomic and proteomic analysis of activation of the human neutrophil by lipopolysaccharide and its mediation by p38 mitogen-activated protein kinase. J Biol Chem 2002; 277: 31291–31302.
Nagai Y, Garrett KP, Ohta S, Bahrun U, Kouro T, Akira S et al. Toll-like receptors on hematopoietic progenitor cells stimulate innate immune system replenishment. Immunity 2006; 24: 801–812.
Zhao Y, Ling F, Wang HC, Sun XH . Chronic TLR signaling impairs the long-term repopulating potential of hematopoietic stem cells of wild type but not id1 deficient mice. PLoS One 2013; 8: e55552.
Rodriguez S, Chora A, Goumnerov B, Mumaw C, Goebel WS, Fernandez L et al. Dysfunctional expansion of hematopoietic stem cells and block of myeloid differentiation in lethal sepsis. Blood 2009; 114: 4064–4076.
Perry SS, Zhao Y, Nie L, Cochrane SW, Huang Z, Sun XH . Id1 but not Id3, directs long-term repopulating hematopoietic stem-cell maintenance. Blood 2007; 110: 2351–2360.
Ichii M, Shimazu T, Welner RS, Garrett KP, Zhang Q, Esplin BL et al. Functional diversity of stem and progenitor cells with B-lymphopoietic potential. Immunol Rev 2010; 237: 10–21.
Velders GA, van Os R, Hagoort H, Verzaal P, Guiot HF, Lindley IJ et al. Reduced stem cell mobilization in mice receiving antibiotic modulation of the intestinal flora: involvement of endotoxins as cofactors in mobilization. Blood 2004; 103: 340–346.
Grassinger J, Williams B, Olsen GH, Haylock DN, Nilsson SK . Granulocyte colony stimulating factor expands hematopoietic stem cells within the central but not endosteal bone marrow region. Cytokine 2012; 58: 218–225.
Bleharski JR, Niazi KR, Sieling PA, Cheng G, Modlin RL . Signaling lymphocytic activation molecule is expressed on CD40 ligand-activated dendritic cells and directly augments production of inflammatory cytokines. J Immunol 2001; 167: 3174–3181.
Farina C, Theil D, Semlinger B, Hohlfeld R, Meinl E . Distinct responses of monocytes to Toll-like receptor ligands and inflammatory cytokines. Int Immunol 2004; 16: 799–809.
Kruse M, Meinl E, Henning G, Kuhnt C, Berchtold S, Berger T et al. Signaling lymphocytic activation molecule is expressed on mature CD83+ dendritic cells and is up-regulated by IL-1 beta. J Immunol 2001; 167: 1989–1995.
Sato T, Laver JH, Ogawa M . Reversible expression of CD34 by murine hematopoietic stem cells. Blood 1999; 94: 2548–2554.
Tajima F, Sato T, Laver JH, Ogawa M . CD34 expression by murine hematopoietic stem cells mobilized by granulocyte colony-stimulating factor. Blood 2000; 96: 1989–1993.
Takizawa H, Regoes RR, Boddupalli CS, Bonhoeffer S, Manz MG . Dynamic variation in cycling of hematopoietic stem cells in steady state and inflammation. J Exp Med 2011; 208: 273–284.
Megias J, Yanez A, Moriano S, O'Connor JE, Gozalbo D, Gil ML . Direct Toll-like receptor-mediated stimulation of hematopoietic stem and progenitor cells occurs in vivo and promotes differentiation toward macrophages. Stem Cells 2012; 30: 1486–1495.
Kamada N, Seo SU, Chen GY, Nunez G . Role of the gut microbiota in immunity and inflammatory disease. Nat Rev Immunol 2013; 13: 321–335.
Frangoul H, Nemecek ER, Billheimer D, Pulsipher MA, Khan S, Woolfrey A et al. A prospective study of G-CSF primed bone marrow as a stem-cell source for allogeneic bone marrow transplantation in children: a Pediatric Blood and Marrow Transplant Consortium (PBMTC) study. Blood 2007; 110: 4584–4587.
Chang YJ, Huang XJ . Use of G-CSF-stimulated marrow in allogeneic hematopoietic stem cell transplantation settings: a comprehensive review. Clin Transplant 2011; 25: 13–23.
Arcese W, De Angelis G, Cerretti R . Granulocyte-mobilized bone marrow. Curr Opin Hematol 2012; 19: 448–453.
Acknowledgements
We thank J Tucker-Davis for animal care. We also thank the Alvin J Siteman Cancer Center at Washington University School of Medicine and Barnes-Jewish Hospital in St. Louis, MO, USA, for the use of the Siteman Flow Cytometry Core, which provided cell sorting and analysis service. The Siteman Cancer Center is supported in part by an NCI Cancer Center Support Grant #P30 CA91842. This work was supported by the NIH grant RO1 HL60772 (to DCL), Alex's Lemonade Stand Foundation (to LGS), the Children's Discovery Institute of Washington University and St Louis Children's Hospital (to LGS), and Hyundai Motor America (Hyundai Hope on Wheels scholar award to LGS). LGS is a scholar of the Child Health Research Center of Excellence in Developmental Biology at Washington University School of Medicine (K12-HD076224).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no conflict of interest.
Additional information
Author Contributions
LGS designed the research, performed the research, analyzed data and wrote the paper. JNB performed the research and analyzed data. MJC designed the research, performed the research and analyzed data. PKG performed the research. MPR performed the research. ACH performed the research. JRW performed the research. AMG designed the research. DCL designed the research, analyzed data and wrote the paper.
Supplementary Information accompanies this paper on the Leukemia website
Supplementary information
Rights and permissions
About this article
Cite this article
Schuettpelz, L., Borgerding, J., Christopher, M. et al. G-CSF regulates hematopoietic stem cell activity, in part, through activation of Toll-like receptor signaling. Leukemia 28, 1851–1860 (2014). https://doi.org/10.1038/leu.2014.68
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/leu.2014.68
This article is cited by
-
Uncovering the multifaceted roles played by neutrophils in allogeneic hematopoietic stem cell transplantation
Cellular & Molecular Immunology (2021)
-
Hematopoietic Stem Cell Stress and Regeneration
Current Stem Cell Reports (2020)
-
Innate immunity orchestrates the mobilization and homing of hematopoietic stem/progenitor cells by engaging purinergic signaling—an update
Purinergic Signalling (2020)
-
MiR-125a enhances self-renewal, lifespan, and migration of murine hematopoietic stem and progenitor cell clones
Scientific Reports (2019)
-
Necroinflammation emerges as a key regulator of hematopoiesis in health and disease
Cell Death & Differentiation (2019)